Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

ObsEva reports follow-up data from phase III IMPLANT2 study of nolasiban

April 29, 2019

European Commission approves Zynquista for type 1 diabetes

April 29, 2019

Novo Nordisk reports phase III results with Victoza in pediatric type 2 diabetes

April 29, 2019

Preclinical results of a systemic mRNA therapy for Fabry disease

April 29, 2019

Melanocortin receptor signaling can cut both ways in obesity

April 25, 2019

Parkinson's drug inhibits obesity gene

April 24, 2019

Novel ovario-hysterectomy-induced rabbit model of postmenopausal osteoporosis

April 18, 2019

Diamyd Medical presents 30-month results from phase IIa EDCR study

April 16, 2019

FDA gives clearance to initiate phase II/III study of ARO-AAT for AATD liver disease

April 16, 2019

RTI-1092663 improves metabolic syndrome in mice

April 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...